AAO Digital GUIDELINES Apps (free trial)

Idiopathic Macular Hole

AAO GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/616782

Contents of this Issue

Navigation

Page 8 of 11

Î The surgeon should instruct the patient about the need for intraocular gas, facedown positioning postoperatively to tamponade the hole, as well as the likely development of a cataract in phakic eyes. (III, G, S) Î Patients with glaucoma should be informed of the possibility of an increase in postoperative intraocular pressure (IOP). (III, G, S) Surgery Î An important anatomic goal of the pars plana vitrectomy is to separate the posterior cortical hyaloid from the retinal surface. Î Triamcinolone acetonide can be injected into the vitreous following a core vitrectomy to highlight the posterior vitreous. Î Retinal tamponade may be created using different agents at the conclusion of macular hole surgery in order to achieve anatomic closure of the macular hole. (III, M, D) Î Tamponade options include the use of air (days), SF 6 (2– 4 weeks), C 3 F 8 (1–3 months), or silicone oil (long-term). (II-, M, D) Î Silicone oil may be used for patients who cannot position facedown, but visual results are better with gas tamponade. (II-, M, D) Î Using silicone oil also requires a second operation for oil removal. (III, G, S) Î No firm recommendations can be made regarding the role of internal limiting membrane (ILM) peeling. (II-, In, D) Î When the surgeon prefers indocyanine green (ICG) to stain the ILM, the lowest possible concentration of ICG should be used. (III, G, S) Î There is no clear consensus for the duration of facedown positioning to seal macular holes following vitrectomy surgery. Longer positioning may be required for holes >400 µm or those with inadequate tamponade. (I+, G, D) Î Follow-up recommendation for Stage 3–4 macular holes treated by vitreoretinal surgery: 1–2 days postoperatively, then 1–2 weeks, depending on the outcome of surgery and the patient's clinical course. (III, G, D) Postoperative Management Î The surgeon is responsible for formulating a postoperative care plan and should inform the patient of these arrangements. (III, G, S)

Articles in this issue

Archives of this issue

view archives of AAO Digital GUIDELINES Apps (free trial) - Idiopathic Macular Hole